Sarah Nemec - Jul 23, 2024 Form 4 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role
VP, Finance and PAO
Signature
/s/ William P. Quinn, Attorney-in-Fact
Stock symbol
BOLT
Transactions as of
Jul 23, 2024
Transactions value $
$0
Form type
4
Date filed
7/24/2024, 05:17 PM
Previous filing
May 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BOLT Stock Option (Right to Buy) Award $0 +50K $0.00 50K Jul 23, 2024 Common Stock 50K $0.73 Direct F1
transaction BOLT Stock Option (Right to Buy) Award $0 +90K $0.00 90K Jul 23, 2024 Common Stock 90K $0.73 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024.
F2 For so long as the Reporting Person continuously provides services to the Issuer this option will vest on July 15, 2025.